GlassScriptPhysician profile
Ronald D Hirth
NPI 1942442322
$6,222.65
in general payments reported to CMS, 2019-2025
36 companies · $1,312 in 2025
The $1,312 reported for 2025 was more than what 92% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $835 · 2020: $172 · 2021: $415 · 2022: $1,119 · 2023: $1,434 · 2024: $936 · 2025: $1,312.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,282 · Consulting Fee: $400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,282.10 |
| Consulting Fee | $400.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $903.59 | 2023-2025 | Myfembree, Gemtesa |
| Abbvie INC. | $799.81 | 2019-2025 | |
| Astellas Pharma US INC | $619.17 | 2020-2025 | Veozah, Myrbetriq |
| Gynesonics, INC. | $502.26 | 2022-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Baxter Healthcare | $452.44 | 2021-2025 | Perclot, Tisseel |
| Therapeuticsmd, INC. | $309.11 | 2019-2022 | |
| Coopersurgical, INC. | $299.27 | 2020-2025 | Paragard T 380a, Paragard T 380a, Endosee |
| Novo Nordisk INC | $261.65 | 2019-2025 | Wegovy |
| Hologic Sales and Service, LLC | $236.68 | 2019-2024 | Fluent Fluid Management System, Novasure, Myosure Tissue Removal Device |
| Channel Medsystems, INC. | $225.05 | 2022-2023 | |
| Exeltis, USA INC. | $153.11 | 2019-2025 | Slynd |
| Ge Healthcare | $139.91 | 2023 | |
| Sage Therapeutics, LLC | $132.84 | 2024-2025 | Zurzuvae |
| Organon LLC | $126.64 | 2021-2025 | Nexplanon |
| Myriad Women'S Health, INC. | $125.00 | 2023 | Myrisk |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $123.96 | 2022-2025 | |
| Exact Sciences Corporation | $90.94 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Pfizer INC. | $79.59 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $79.19 | 2019-2025 | Gardasil 9, Gardasil |
| Bayer Healthcare Pharmaceuticals INC. | $73.99 | 2019-2023 | |
| Currax Pharmaceuticals LLC | $72.15 | 2021-2024 | Contrave |
| Millicent US INC | $65.51 | 2025 | Femlyv, Intrarosa |
| Agile Therapeutics, INC. | $58.02 | 2022-2023 | Twirla |
| Shield Therapeutics INC | $49.50 | 2023-2024 | Accrufer |
| Lilly USA, LLC | $43.20 | 2024-2025 | Zepbound |
| Ethicon US, LLC | $36.06 | 2022-2024 | Stratafix, Dermabond Prineo, Ethicon |
| Lupin INC. | $29.33 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $22.05 | 2025 | Ultomiris |
| Urovant Sciences INC | $21.40 | 2022 | |
| Medtronic Minimed, INC. | $18.18 | 2019 | |
| Allergan, INC. | $17.67 | 2020 | |
| Amgen INC. | $15.90 | 2021 | |
| Pharmacosmos Therapeutics INC. | $14.62 | 2021 | |
| Amag Pharmaceuticals, INC. | $13.05 | 2019 | |
| Scynexis, INC. | $11.81 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Hirth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.